Gujarat Kidney & Super Speciality is all set to launch its initial public offering (IPO) on December 22. The mainboard IPO will remain open till December 24.
The healthcare company has announced the price band for its upcoming IPO. Gujarat Kidney & Super Speciality IPO has fixed the IPO price band at ₹108 to ₹114, with a face value of ₹2 per share.
The ₹250.8 crore IPO consists entirely of a fresh issue of 2.20 crore shares, with no offer-for-sale component.
The funds raised will be utilised for acquiring Parekhs Hospital Private Limited in Ahmedabad, making a partial payment for the already acquired Ashwini Medical Centre, increasing the company’s stake in its subsidiary Harmony Medicare Pvt Ltd in Bharuch, and meeting capital expenditure requirements for setting up a dedicated women’s healthcare hospital in Vadodara. Additionally, the proceeds will be used to purchase robotic medical equipment, reduce debt, support inorganic expansion through yet-to-be-identified acquisitions, and meet general corporate purposes.
Each lot comprises 128 shares and can be applied for in multiples of this size. Of the net issue, 75% has been allocated to qualified institutional buyers, 15% to non-institutional investors, and the remaining 10% to retail investors.
The Offer is being made through the book-building process, wherein not more than 75% of the net offer is allocated to qualified institutional buyers, and not more than 15% and 10% of the net offer is assigned to non-institutional bidders and retail individual bidders respectively.
The allotment of Gujarat Kidney & Super Speciality IPO will be finalised on December 26. Meanwhile, the IPO will list on both BSE, NSE with a tentative listing date fixed as December 30.
Nirbhay Capital Services Private Limited is the book-running lead manager; and MUFG Intime India Limited is the registrar of the offer.
Gujarat Kidney & Super Speciality IPO GMP today
The shares of Gujarat Kidney & Super Speciality IPO is currently not trading in the grey market, as per investorgain.
This means that the GMP of Gujarat Kidney & Super Speciality IPO is currently +0.
About the company
Gujarat Kidney and Super Speciality is a Gujarat-based regional healthcare provider that operates a network of mid-sized multi-speciality hospitals. The company delivers integrated healthcare services with an emphasis on secondary and tertiary care.
Its portfolio includes seven multi-speciality hospitals along with four in-hospital pharmacies. The facilities comprise Gujarat Kidney and Superspeciality Hospital (Vadodara), Raj Palmland Hospital Private Limited (Bharuch), Gujarat Multispeciality Hospital (Godhra), Surya Hospital and ICU (Borsad), Ashwini Medical Centre and Ashwini Medical Store (Anand), Gujarat Surgical Hospital (Vadodara), and Apex Multispeciality & Trauma Center (Bharuch).
Disclaimer: This story is for educational purposes only. Please consult with an investment advisor before making any investment decisions.
